#United States #Livermore #Precision Cell #S2 Genomics #ORFLO

Precision Cell Systems Launches to Innovate Cell Analysis

In a significant move for the life sciences sector, Precision Cell Systems (PCS) has officially announced its launch following strategic acquisitions of S2 Genomics and ORFLO. This initiative aims to tackle critical bottlenecks in cell analysis workflows, empowering over 700 active customers and boasting more than 1,000 installed instruments worldwide. Backed by 25 patents and over 500 scientific publications, PCS is set to provide cutting-edge solutions in cell analysis that enhance reproducibility and efficiency in research labs.

To lead this exciting venture, PCS has gathered a robust team of industry veterans. Anup Parikh, PhD, a well-respected figure with previous leadership experience at Mission Bio and 10X Genomics, takes the helm as CEO. He is joined by Chief Commercial Officer Terry Salyer, known for his success in driving revenues at Unchained Labs and ProteinSimple, and Chief Operating Officer Bruce Leisz, who brings a wealth of operational experience from Pacific Biosciences and Affymetrix.

Anup Parikh elaborated on the challenges faced by many technologies in the current market: “In today's challenging market, many technologies that solve critical problems are stranded because of financial and operational gaps,” he commented. PCS aims to bridge these gaps and transform promising innovations into sustainable, profitable businesses. With the integration of S2 and ORFLO under its umbrella, PCS has already reduced combined operating expenses by more than 35% while achieving revenue growth shortly after the acquisitions.

One of the standout innovations that PCS brings to the table is the Singulator platform. This technology addresses two significant pain points in cell analysis: it simplifies and enhances the consistency of tissue dissociation processes, traditionally reliant on labor-intensive manual methods. Notably, the Moxi products enable flow cytometry-quality cell counting through a revolutionary disposable cassette technology. This forward-thinking approach not only minimizes workflow complexity but also accelerates the time-to-result for laboratories engaged in advanced cellular research.

Feedback from leading research institutions highlights the impact of the Singulator platform. Ronan Chaligne, PhD, a researcher at Memorial Sloan Kettering Cancer Center, shared, “What sets Singulator apart is its reliability and consistency compared to manual preparation. We depend on it as a walk-up service in our core lab... I don't know of any other way to achieve such consistent nuclei extraction today.” This level of reproducibility has been corroborated across more than 30 peer-reviewed publications focusing on cancer research, immunotherapy, and drug development.

As PCS carves its niche in the life sciences landscape, the company intends to foster organic growth while ensuring operational efficiency. Additionally, it actively seeks further acquisitions, focusing on technologies that complement current offerings, including sample preparation, functional cellular and molecular assays, and advanced data solutions. By building a comprehensive cell analysis workflow platform, PCS aims to support researchers and drug developers with reliable, market-ready solutions.

For more information on Precision Cell Systems and its innovative technologies, visit www.precisioncellsystems.com.

About Precision Cell Systems

Precision Cell Systems is dedicated to transforming groundbreaking technologies into sustainable business ventures within the field of cell analysis. By integrating complementary workflow technologies and streamlining operations, PCS equips researchers and drug developers with efficient, reliable tools for cellular exploration.

About BroadOak Capital Partners

BroadOak Capital Partners specializes in financial investment and banking services tailored to life science tool companies, diagnostics, and biopharmaceutical services. With participation in over 70 endeavors within the life sciences realm, they lend support to enterprises looking to thrive in this ever-evolving industry.